Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer

Ann Transl Med. 2021 Jan;9(1):2. doi: 10.21037/atm-20-7534.

Authors

Pauline Viviane Pocha¹, Chencheng Xie^{2

3}, Christine Pocha^{2

3}

Affiliations

¹ School of Medicine, University College of Dublin, Dublin, Ireland.
² Department of Medicine, Avera McKennan Hospital and University Center, Sioux Falls, SD, USA.
³ Sanford School of Medicine, Sanford School of Medicine, University of South Dakota, Vermillion, SD, USA.

No abstract available

Publication types

Editorial
Comment